Stocktoria
PRO DEX INC PDEX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1994-05-31
PRO DEX INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 29.3% | 27.0% | 27.7% | 31.2% | 35.7% |
| Operating margin | 16.1% | 13.3% | 12.5% | 12.2% | 11.9% |
| Net margin | 13.5% | 4.0% | 15.3% | 10.9% | 16.2% |
| FCF margin | — | — | — | -5.9% | -10.1% |
| Return on assets | 14.7% | 4.1% | 13.7% | 9.3% | 15.3% |
| Return on equity | 24.5% | 6.9% | 22.4% | 18.0% | 29.2% |
| Debt / equity | 0.42× | 0.39× | 0.41× | 0.53× | 0.61× |
| Current ratio | 3.23 | 2.84 | 3.20 | 2.74 | 3.99 |
| Revenue growth | 23.7% | 16.8% | 9.6% | 10.5% | 9.2% |
Source: SEC EDGAR filings · CIK 0000788920 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.